MDM2 and MDMX can interact differently with ARF and members of the p53 family

被引:73
|
作者
Wang, XQ
Arooz, T
Siu, WY
Chiu, CHS
Lau, A
Yamashita, K
Poon, RYC
机构
[1] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
[2] Kanazawa Univ, Grad Sch Nat Sci & Technol, Dept Life Sci, Kanazawa, Ishikawa 9201192, Japan
关键词
ARF; MDM2; MDMX; p53; p63; p73; tumor suppressor;
D O I
10.1016/S0014-5793(01)02124-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of the p53 family of transcription factors have essential roles in tumor suppression and in development, MDM2 is an essential regulator of p53 that can inhibit the transcriptional activity of p53, shuttle p53 out of the nucleus, and target p53 for ubiquitination-mediated degradation. Little is known about the interaction and selectivity of different members of the p53 family (p53, p63, and p73) and the MDM2 family (MDM2 and MDMX). Here we show that the transcriptional activities of p53 and p73, but not that of p63, were inhibited by both MDM2 and MDMX. Consistent with these, we found that MDMX can physically interact with p53 and p73, but not with p63, Moreover, ectopically expressed MDM2 and MDMX could induce alterations in the subcellular localization of p73, but did not affect the subcellular localization of p53 and p63. Finally, we demonstrate that while ARF can interact with MDM2 and inhibit the regulation of p53 by MDM2. no interaction was found between ARF and MDMX. These data reveal that significant differences and selectivity exist between the regulation of different members of the p53 family by MDM2 and MDMX. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 50 条
  • [31] Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms
    Stad, R
    Little, NA
    Xirodimas, DP
    Frenk, R
    van der Eb, AJ
    Lane, DP
    Saville, MK
    Jochemsen, AG
    EMBO REPORTS, 2001, 2 (11) : 1029 - 1034
  • [32] Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX
    Li, Hongjin
    Chen, Xiangyan
    Wu, Minghao
    Song, Panpan
    Zhao, Xia
    CHINESE CHEMICAL LETTERS, 2022, 33 (03) : 1254 - 1258
  • [33] Bicyclic stapled peptides based on p53 as dual inhibitors for the interactions of p53 with MDM2 and MDMX
    Hongjin Li
    Xiangyan Chen
    Minghao Wu
    Panpan Song
    Xia Zhao
    Chinese Chemical Letters, 2022, 33 (03) : 1254 - 1258
  • [34] Control of p53 ubiquitination and nuclear export by MDM2 and ARF
    Zhang, YP
    Xiong, Y
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (04): : 175 - 186
  • [35] MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
    Wang, Xinjiang
    Wang, Junru
    Jiang, Xuejun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (27) : 23725 - 23734
  • [36] p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
    Karakostis, Konstantinos
    Ponnuswamy, Anand
    Fusee, Leila T. S.
    Bailly, Xavier
    Laguerre, Laurent
    Worall, Erin
    Vojtesek, Borek
    Nylander, Karin
    Fahraeus, Robin
    MOLECULAR BIOLOGY AND EVOLUTION, 2016, 33 (05) : 1280 - 1292
  • [37] Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX
    Hu, Baoli
    Gilkes, Daniele M.
    Chen, Jiandong
    CANCER RESEARCH, 2007, 67 (18) : 8810 - 8817
  • [38] The p53/MDM2/MDMX-targeted therapies-a clinical synopsis
    Jiang, Liren
    Zawacka-Pankau, Joanna
    CELL DEATH & DISEASE, 2020, 11 (04)
  • [39] Conservation of all three p53 family members and Mdm2 and Mdm4 in the cartilaginous fish
    Lane, David P.
    Madhumalar, Arumugam
    Lee, Alison P.
    Tay, Boon-Hui
    Verma, Chandra
    Brenner, Sydney
    Venkatesh, Byrappa
    CELL CYCLE, 2011, 10 (24) : 4272 - 4279
  • [40] Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis
    Lynette Moore
    Sundaresan Venkatachalam
    Hannes Vogel
    Julie C Watt
    Chao-Ling Wu
    Heather Steinman
    Stephen N Jones
    Lawrence A Donehower
    Oncogene, 2003, 22 : 7831 - 7837